Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+11.07%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$25.2B
AUM Growth
+$4.86B
(+24%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
11.61%
Top 10 Holdings %
Top 10 Hldgs %
25.97%
Holding
1,178
New
57
Increased
860
Reduced
151
Closed
43
Top Buys
| 1 |
Apple
AAPL
|
$215M |
| 2 |
Microsoft
MSFT
|
$181M |
| 3 |
Amazon
AMZN
|
$112M |
| 4 |
Tesla
TSLA
|
$80.9M |
| 5 |
Meta Platforms (Facebook)
META
|
$66.7M |
Top Sells
| 1 |
iShares Global REIT ETF
REET
|
$20.2M |
| 2 |
JD.com
JD
|
$15.7M |
| 3 |
Ambarella
AMBA
|
$14.2M |
| 4 |
TopBuild
BLD
|
$12M |
| 5 |
NetEase
NTES
|
$10.9M |
Sector Composition
| 1 | Technology | 26.54% |
| 2 | Consumer Discretionary | 12.51% |
| 3 | Healthcare | 12.26% |
| 4 | Financials | 11.23% |
| 5 | Communication Services | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Vericel Corp
VCEL
$1.72B
| $277K | ﹤0.01% |
6,742
+764
| +13% | +$31.4K |
|
|
CLDT
1027
Chatham Lodging
CLDT
$363M
| $275K | ﹤0.01% |
20,063
+2,344
| +13% | +$32.1K |
|
1028
CRISPR Therapeutics
CRSP
$4.99B
| $275K | ﹤0.01% |
3,467
+668
| +24% | +$53K |
|
1029
Open Lending Corp
LPRO
$267M
| $275K | ﹤0.01% |
11,677
+2,893
| +33% | +$68.1K |
|
1030
Atara Biotherapeutics
ATRA
$90.7M
| $272K | ﹤0.01% |
645
-227
| -26% | -$95.7K |
|
1031
Phillips Edison & Co
PECO
$4.54B
| $271K | ﹤0.01% |
+8,043
| New | +$271K |
|
1032
CVRx
CVRX
$204M
| $270K | ﹤0.01% |
+21,818
| New | +$270K |
|
1033
Recursion Pharmaceuticals
RXRX
$2.01B
| $270K | ﹤0.01% |
+14,957
| New | +$270K |
|
1034
Green Dot
GDOT
$760M
| $267K | ﹤0.01% |
7,206
-746
| -9% | -$27.6K |
|
1035
PagSeguro Digital
PAGS
$2.8B
| $263K | ﹤0.01% |
9,204
+2,371
| +35% | +$67.8K |
|
|
VNET
1036
VNET Group
VNET
$2.13B
| $263K | ﹤0.01% |
29,174
| – | – |
|
|
ALX
1037
Alexander's
ALX
$1.2B
| $260K | ﹤0.01% |
974
+234
| +32% | +$62.5K |
|
1038
Taysha Gene Therapies
TSHA
$917M
| $259K | ﹤0.01% |
+21,834
| New | +$259K |
|
|
CD
1039
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $258K | ﹤0.01% |
40,600
+20,000
| +97% | +$127K |
|
|
BTCM
1040
BIT Mining
BTCM
$46.6M
| $256K | ﹤0.01% |
4,103
-282
| -6% | -$17.6K |
|
1041
Novo Nordisk
NVO
$245B
| $256K | ﹤0.01% |
+4,700
| New | +$256K |
|
1042
Intellia Therapeutics
NTLA
$1.29B
| $254K | ﹤0.01% |
2,132
-2,601
| -55% | -$310K |
|
1043
Rocket Pharmaceuticals
RCKT
$354M
| $252K | ﹤0.01% |
10,629
+3,043
| +40% | +$72.1K |
|
1044
BioNTech
BNTX
$27B
| $251K | ﹤0.01% |
1,084
-448
| -29% | -$104K |
|
1045
Paysafe
PSFE
$864M
| $251K | ﹤0.01% |
+5,169
| New | +$251K |
|
1046
Marqeta
MQ
$2.76B
| $250K | ﹤0.01% |
+13,891
| New | +$250K |
|
1047
Codexis
CDXS
$218M
| $247K | ﹤0.01% |
7,734
-8,378
| -52% | -$268K |
|
1048
CureVac
CVAC
$1.21B
| $247K | ﹤0.01% |
7,002
+4,335
| +163% | +$153K |
|
1049
Precision BioSciences
DTIL
$59.8M
| $244K | ﹤0.01% |
1,050
-38
| -3% | -$8.83K |
|
1050
Novartis
NVS
$251B
| $244K | ﹤0.01% |
2,781
+268
| +11% | +$23.5K |
|